Status:
COMPLETED
Incorporating Patient-Reported Outcomes Into Shared Decision Making With Patients With Osteoarthritis of the Hip or Knee
Lead Sponsor:
University of Texas at Austin
Conditions:
Osteo Arthritis Knee
Eligibility:
All Genders
45-89 years
Phase:
NA
Brief Summary
Osteoarthritis (OA) of the knee constitutes a major public health problem. Treatment options for knee OA range from lifestyle changes to pharmacological management to total knee replacement surgery. A...
Eligibility Criteria
Inclusion
- New patients
- Presumptive diagnosis of knee OA
- Aged 45 to 89
- K-L Joint OA severity grade 3 to 4 (moderate to severe)
- KOOS JR score 0-85
- Able to consent
Exclusion
- Prior total knee replacement (TKR)
- Prior consultation with orthopaedic surgeons for TKR
- Prior experience with Joint Insights
- Trauma condition or psoriatic/rheumatoid arthritis
- Non-English or Non-Spanish speakers
- BMI \<20 or \>46
Key Trial Info
Start Date :
February 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04805554
Start Date
February 22 2021
End Date
May 30 2023
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT Health Austin Musculoskeletal Institute
Austin, Texas, United States, 78712